0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sterile Lancets Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-24Q6594
Home | Market Reports | Health| Medical Devices & Equipment
Global Sterile Lancets Market Insights and Forecast to 2028
BUY CHAPTERS

Global Sterile Lancets Market Research Report 2025

Code: QYRE-Auto-24Q6594
Report
August 2025
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sterile Lancets Market Size

The global market for Sterile Lancets was valued at US$ 1674 million in the year 2024 and is projected to reach a revised size of US$ 2288 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Sterile Lancets Market

Sterile Lancets Market

Sterile Lancets are small, single-use devices with a sharp needle that are used to puncture the skin, typically the fingertip, to collect a blood sample. These Sterile Lancets are pre-sterilized to prevent infections and are commonly used for blood glucose monitoring and other diagnostic tests. Since they are designed for one-time use, Sterile Lancets help reduce the risk of cross-contamination and infection, making them a safe option for home and clinical settings.
Market Drivers:
Growing prevalence of chronic diseases: The rise in chronic conditions like diabetes, which require regular blood glucose monitoring, is a significant driver for lancet demand. As the number of diabetes patients increases globally, the need for Sterile Lancets continues to grow.
Technological advancements in Sterile Lancets: Innovations such as ultra-thin needles, painless lancet designs, and easy-to-use lancet devices improve user experience, making blood sampling more comfortable and encouraging more frequent use.
Increase in home-based healthcare: The trend toward home healthcare and self-monitoring for various conditions, especially diabetes, has driven the use of Sterile Lancets. This allows patients to monitor their health in a more convenient and cost-effective way, increasing the market for these devices.
Aging population: The growing elderly population is more prone to chronic diseases like diabetes, requiring regular blood monitoring. This demographic shift is a major factor pushing the demand for Sterile Lancets and other monitoring devices.
Rising awareness of preventive healthcare: Increasing awareness of the importance of regular health monitoring, especially for managing conditions like diabetes, has led to higher adoption of Sterile Lancets for routine blood tests and glucose monitoring.
Market Challenges:
Competition from alternative technologies: Non-invasive blood glucose monitoring methods (such as continuous glucose monitors or sensor-based systems) are gaining traction, potentially reducing the reliance on traditional Sterile Lancets for blood sampling.
High recurring costs for patients: Sterile Lancets are single-use devices, and the recurring cost for people who need frequent testing can become a financial burden, particularly in low-income regions or for uninsured patients, limiting market growth.
Infection risks: Improper or repeated use of Sterile Lancets can lead to infections, particularly if they are not disposed of properly or if reused by mistake, which poses a health risk and deters their use.
Environmental concerns: Sterile Lancets contribute to medical waste, as they are disposable devices, raising concerns about environmental impact. This could lead to regulatory pressures or a shift toward more sustainable alternatives.
Regulatory compliance and approval hurdles: The lancet market is subject to stringent regulations and approval processes from health authorities. This can slow down the introduction of new products and innovations, delaying their availability in the market.
The classification of Sterile Lancets includes Ordinary Sterile Lancets and Safety Sterile Lancets. In 2023, Ordinary Sterile Lancets accounted for a share of 61.81% in the global Sterile Lancets market. With several hospitals and healthcare facilities converting to safety Sterile Lancets, this market share is poised for declined. Americas is the largest consumption place, with a consumption market share nearly 40 % in 2022. Following Americas, Europe is the second largest consumption place with the consumption market share of 30 %.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sterile Lancets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sterile Lancets.
The Sterile Lancets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sterile Lancets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sterile Lancets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Sterile Lancets Market Report

Report Metric Details
Report Name Sterile Lancets Market
Accounted market size in year US$ 1674 million
Forecasted market size in 2031 US$ 2288 million
CAGR 4.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Children's Fingertip Blood Tests
  • Glucose Tests
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Lifescan, BD, Ascensia, Abbott, B. Braun, ARKRAY, Terumo, I-SENS, Nipro, Cardinal Health, ICU Medical, Sarstedt, Sinocare, Yicheng, Yuwell, Greiner Bio One, Guangzhou iCare Medical, Shandong Lianfa, Tianjin Huahong, Owen Mumford, HemoCue, HTL-STREFA, UltiMed, SteriLance Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Sterile Lancets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Sterile Lancets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Sterile Lancets Market growing?

Ans: The Sterile Lancets Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Sterile Lancets Market size in 2031?

Ans: The Sterile Lancets Market size in 2031 will be US$ 2288 million.

What is the Sterile Lancets Market share by region?

Ans: Americas is the largest consumption place, with a consumption market share nearly 40 % in 2022.

Who are the main players in the Sterile Lancets Market report?

Ans: The main players in the Sterile Lancets Market are Roche, Lifescan, BD, Ascensia, Abbott, B. Braun, ARKRAY, Terumo, I-SENS, Nipro, Cardinal Health, ICU Medical, Sarstedt, Sinocare, Yicheng, Yuwell, Greiner Bio One, Guangzhou iCare Medical, Shandong Lianfa, Tianjin Huahong, Owen Mumford, HemoCue, HTL-STREFA, UltiMed, SteriLance Medical

What are the Application segmentation covered in the Sterile Lancets Market report?

Ans: The Applications covered in the Sterile Lancets Market report are Children's Fingertip Blood Tests, Glucose Tests, Others

What are the Type segmentation covered in the Sterile Lancets Market report?

Ans: The Types covered in the Sterile Lancets Market report are Safety Lancets, Ordinary Lancets

Recommended Reports

Lancets & Blood Collection

Needles & Micro-sampling

Diabetes Testing Supplies

1 Sterile Lancets Market Overview
1.1 Product Definition
1.2 Sterile Lancets by Type
1.2.1 Global Sterile Lancets Market Value Comparison by Type (2024 VS 2031)
1.2.2 Safety Lancets
1.2.3 Ordinary Lancets
1.3 Sterile Lancets by Application
1.3.1 Global Sterile Lancets Market Value by Application (2024 VS 2031)
1.3.2 Children's Fingertip Blood Tests
1.3.3 Glucose Tests
1.3.4 Others
1.4 Global Sterile Lancets Market Size Estimates and Forecasts
1.4.1 Global Sterile Lancets Revenue 2020-2031
1.4.2 Global Sterile Lancets Sales 2020-2031
1.4.3 Global Sterile Lancets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Sterile Lancets Market Competition by Manufacturers
2.1 Global Sterile Lancets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Sterile Lancets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Sterile Lancets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Sterile Lancets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sterile Lancets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sterile Lancets, Product Type & Application
2.7 Global Key Manufacturers of Sterile Lancets, Date of Enter into This Industry
2.8 Global Sterile Lancets Market Competitive Situation and Trends
2.8.1 Global Sterile Lancets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Sterile Lancets Players Market Share by Revenue
2.8.3 Global Sterile Lancets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sterile Lancets Market Scenario by Region
3.1 Global Sterile Lancets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Sterile Lancets Sales by Region: 2020-2031
3.2.1 Global Sterile Lancets Sales by Region: 2020-2025
3.2.2 Global Sterile Lancets Sales by Region: 2026-2031
3.3 Global Sterile Lancets Revenue by Region: 2020-2031
3.3.1 Global Sterile Lancets Revenue by Region: 2020-2025
3.3.2 Global Sterile Lancets Revenue by Region: 2026-2031
3.4 North America Sterile Lancets Market Facts & Figures by Country
3.4.1 North America Sterile Lancets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Sterile Lancets Sales by Country (2020-2031)
3.4.3 North America Sterile Lancets Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sterile Lancets Market Facts & Figures by Country
3.5.1 Europe Sterile Lancets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Sterile Lancets Sales by Country (2020-2031)
3.5.3 Europe Sterile Lancets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sterile Lancets Market Facts & Figures by Region
3.6.1 Asia Pacific Sterile Lancets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Sterile Lancets Sales by Region (2020-2031)
3.6.3 Asia Pacific Sterile Lancets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Sterile Lancets Market Facts & Figures by Country
3.7.1 Latin America Sterile Lancets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Sterile Lancets Sales by Country (2020-2031)
3.7.3 Latin America Sterile Lancets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sterile Lancets Market Facts & Figures by Country
3.8.1 Middle East and Africa Sterile Lancets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Sterile Lancets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Sterile Lancets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sterile Lancets Sales by Type (2020-2031)
4.1.1 Global Sterile Lancets Sales by Type (2020-2025)
4.1.2 Global Sterile Lancets Sales by Type (2026-2031)
4.1.3 Global Sterile Lancets Sales Market Share by Type (2020-2031)
4.2 Global Sterile Lancets Revenue by Type (2020-2031)
4.2.1 Global Sterile Lancets Revenue by Type (2020-2025)
4.2.2 Global Sterile Lancets Revenue by Type (2026-2031)
4.2.3 Global Sterile Lancets Revenue Market Share by Type (2020-2031)
4.3 Global Sterile Lancets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Sterile Lancets Sales by Application (2020-2031)
5.1.1 Global Sterile Lancets Sales by Application (2020-2025)
5.1.2 Global Sterile Lancets Sales by Application (2026-2031)
5.1.3 Global Sterile Lancets Sales Market Share by Application (2020-2031)
5.2 Global Sterile Lancets Revenue by Application (2020-2031)
5.2.1 Global Sterile Lancets Revenue by Application (2020-2025)
5.2.2 Global Sterile Lancets Revenue by Application (2026-2031)
5.2.3 Global Sterile Lancets Revenue Market Share by Application (2020-2031)
5.3 Global Sterile Lancets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Sterile Lancets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Sterile Lancets Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Lifescan
6.2.1 Lifescan Company Information
6.2.2 Lifescan Description and Business Overview
6.2.3 Lifescan Sterile Lancets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Lifescan Sterile Lancets Product Portfolio
6.2.5 Lifescan Recent Developments/Updates
6.3 BD
6.3.1 BD Company Information
6.3.2 BD Description and Business Overview
6.3.3 BD Sterile Lancets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BD Sterile Lancets Product Portfolio
6.3.5 BD Recent Developments/Updates
6.4 Ascensia
6.4.1 Ascensia Company Information
6.4.2 Ascensia Description and Business Overview
6.4.3 Ascensia Sterile Lancets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ascensia Sterile Lancets Product Portfolio
6.4.5 Ascensia Recent Developments/Updates
6.5 Abbott
6.5.1 Abbott Company Information
6.5.2 Abbott Description and Business Overview
6.5.3 Abbott Sterile Lancets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Abbott Sterile Lancets Product Portfolio
6.5.5 Abbott Recent Developments/Updates
6.6 B. Braun
6.6.1 B. Braun Company Information
6.6.2 B. Braun Description and Business Overview
6.6.3 B. Braun Sterile Lancets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 B. Braun Sterile Lancets Product Portfolio
6.6.5 B. Braun Recent Developments/Updates
6.7 ARKRAY
6.7.1 ARKRAY Company Information
6.7.2 ARKRAY Description and Business Overview
6.7.3 ARKRAY Sterile Lancets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 ARKRAY Sterile Lancets Product Portfolio
6.7.5 ARKRAY Recent Developments/Updates
6.8 Terumo
6.8.1 Terumo Company Information
6.8.2 Terumo Description and Business Overview
6.8.3 Terumo Sterile Lancets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Terumo Sterile Lancets Product Portfolio
6.8.5 Terumo Recent Developments/Updates
6.9 I-SENS
6.9.1 I-SENS Company Information
6.9.2 I-SENS Description and Business Overview
6.9.3 I-SENS Sterile Lancets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 I-SENS Sterile Lancets Product Portfolio
6.9.5 I-SENS Recent Developments/Updates
6.10 Nipro
6.10.1 Nipro Company Information
6.10.2 Nipro Description and Business Overview
6.10.3 Nipro Sterile Lancets Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Nipro Sterile Lancets Product Portfolio
6.10.5 Nipro Recent Developments/Updates
6.11 Cardinal Health
6.11.1 Cardinal Health Company Information
6.11.2 Cardinal Health Description and Business Overview
6.11.3 Cardinal Health Sterile Lancets Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Cardinal Health Sterile Lancets Product Portfolio
6.11.5 Cardinal Health Recent Developments/Updates
6.12 ICU Medical
6.12.1 ICU Medical Company Information
6.12.2 ICU Medical Description and Business Overview
6.12.3 ICU Medical Sterile Lancets Sales, Revenue and Gross Margin (2020-2025)
6.12.4 ICU Medical Sterile Lancets Product Portfolio
6.12.5 ICU Medical Recent Developments/Updates
6.13 Sarstedt
6.13.1 Sarstedt Company Information
6.13.2 Sarstedt Description and Business Overview
6.13.3 Sarstedt Sterile Lancets Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Sarstedt Sterile Lancets Product Portfolio
6.13.5 Sarstedt Recent Developments/Updates
6.14 Sinocare
6.14.1 Sinocare Company Information
6.14.2 Sinocare Description and Business Overview
6.14.3 Sinocare Sterile Lancets Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Sinocare Sterile Lancets Product Portfolio
6.14.5 Sinocare Recent Developments/Updates
6.15 Yicheng
6.15.1 Yicheng Company Information
6.15.2 Yicheng Description and Business Overview
6.15.3 Yicheng Sterile Lancets Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Yicheng Sterile Lancets Product Portfolio
6.15.5 Yicheng Recent Developments/Updates
6.16 Yuwell
6.16.1 Yuwell Company Information
6.16.2 Yuwell Description and Business Overview
6.16.3 Yuwell Sterile Lancets Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Yuwell Sterile Lancets Product Portfolio
6.16.5 Yuwell Recent Developments/Updates
6.17 Greiner Bio One
6.17.1 Greiner Bio One Company Information
6.17.2 Greiner Bio One Description and Business Overview
6.17.3 Greiner Bio One Sterile Lancets Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Greiner Bio One Sterile Lancets Product Portfolio
6.17.5 Greiner Bio One Recent Developments/Updates
6.18 Guangzhou iCare Medical
6.18.1 Guangzhou iCare Medical Company Information
6.18.2 Guangzhou iCare Medical Description and Business Overview
6.18.3 Guangzhou iCare Medical Sterile Lancets Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Guangzhou iCare Medical Sterile Lancets Product Portfolio
6.18.5 Guangzhou iCare Medical Recent Developments/Updates
6.19 Shandong Lianfa
6.19.1 Shandong Lianfa Company Information
6.19.2 Shandong Lianfa Description and Business Overview
6.19.3 Shandong Lianfa Sterile Lancets Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Shandong Lianfa Sterile Lancets Product Portfolio
6.19.5 Shandong Lianfa Recent Developments/Updates
6.20 Tianjin Huahong
6.20.1 Tianjin Huahong Company Information
6.20.2 Tianjin Huahong Description and Business Overview
6.20.3 Tianjin Huahong Sterile Lancets Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Tianjin Huahong Sterile Lancets Product Portfolio
6.20.5 Tianjin Huahong Recent Developments/Updates
6.21 Owen Mumford
6.21.1 Owen Mumford Company Information
6.21.2 Owen Mumford Description and Business Overview
6.21.3 Owen Mumford Sterile Lancets Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Owen Mumford Sterile Lancets Product Portfolio
6.21.5 Owen Mumford Recent Developments/Updates
6.22 HemoCue
6.22.1 HemoCue Company Information
6.22.2 HemoCue Description and Business Overview
6.22.3 HemoCue Sterile Lancets Sales, Revenue and Gross Margin (2020-2025)
6.22.4 HemoCue Sterile Lancets Product Portfolio
6.22.5 HemoCue Recent Developments/Updates
6.23 HTL-STREFA
6.23.1 HTL-STREFA Company Information
6.23.2 HTL-STREFA Description and Business Overview
6.23.3 HTL-STREFA Sterile Lancets Sales, Revenue and Gross Margin (2020-2025)
6.23.4 HTL-STREFA Sterile Lancets Product Portfolio
6.23.5 HTL-STREFA Recent Developments/Updates
6.24 UltiMed
6.24.1 UltiMed Company Information
6.24.2 UltiMed Description and Business Overview
6.24.3 UltiMed Sterile Lancets Sales, Revenue and Gross Margin (2020-2025)
6.24.4 UltiMed Sterile Lancets Product Portfolio
6.24.5 UltiMed Recent Developments/Updates
6.25 SteriLance Medical
6.25.1 SteriLance Medical Company Information
6.25.2 SteriLance Medical Description and Business Overview
6.25.3 SteriLance Medical Sterile Lancets Sales, Revenue and Gross Margin (2020-2025)
6.25.4 SteriLance Medical Sterile Lancets Product Portfolio
6.25.5 SteriLance Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sterile Lancets Industry Chain Analysis
7.2 Sterile Lancets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sterile Lancets Production Mode & Process Analysis
7.4 Sterile Lancets Sales and Marketing
7.4.1 Sterile Lancets Sales Channels
7.4.2 Sterile Lancets Distributors
7.5 Sterile Lancets Customer Analysis
8 Sterile Lancets Market Dynamics
8.1 Sterile Lancets Industry Trends
8.2 Sterile Lancets Market Drivers
8.3 Sterile Lancets Market Challenges
8.4 Sterile Lancets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Sterile Lancets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Sterile Lancets Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Sterile Lancets Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Sterile Lancets Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Sterile Lancets Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Sterile Lancets Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Sterile Lancets Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Sterile Lancets Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Sterile Lancets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Sterile Lancets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Sterile Lancets, Product Type & Application
 Table 12. Global Key Manufacturers of Sterile Lancets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Sterile Lancets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile Lancets as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Sterile Lancets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Sterile Lancets Sales by Region (2020-2025) & (K Units)
 Table 18. Global Sterile Lancets Sales Market Share by Region (2020-2025)
 Table 19. Global Sterile Lancets Sales by Region (2026-2031) & (K Units)
 Table 20. Global Sterile Lancets Sales Market Share by Region (2026-2031)
 Table 21. Global Sterile Lancets Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Sterile Lancets Revenue Market Share by Region (2020-2025)
 Table 23. Global Sterile Lancets Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Sterile Lancets Revenue Market Share by Region (2026-2031)
 Table 25. North America Sterile Lancets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Sterile Lancets Sales by Country (2020-2025) & (K Units)
 Table 27. North America Sterile Lancets Sales by Country (2026-2031) & (K Units)
 Table 28. North America Sterile Lancets Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Sterile Lancets Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Sterile Lancets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Sterile Lancets Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Sterile Lancets Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Sterile Lancets Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Sterile Lancets Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Sterile Lancets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Sterile Lancets Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Sterile Lancets Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Sterile Lancets Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Sterile Lancets Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Sterile Lancets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Sterile Lancets Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Sterile Lancets Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Sterile Lancets Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Sterile Lancets Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Sterile Lancets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Sterile Lancets Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Sterile Lancets Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Sterile Lancets Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Sterile Lancets Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Sterile Lancets Sales (K Units) by Type (2020-2025)
 Table 51. Global Sterile Lancets Sales (K Units) by Type (2026-2031)
 Table 52. Global Sterile Lancets Sales Market Share by Type (2020-2025)
 Table 53. Global Sterile Lancets Sales Market Share by Type (2026-2031)
 Table 54. Global Sterile Lancets Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Sterile Lancets Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Sterile Lancets Revenue Market Share by Type (2020-2025)
 Table 57. Global Sterile Lancets Revenue Market Share by Type (2026-2031)
 Table 58. Global Sterile Lancets Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Sterile Lancets Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Sterile Lancets Sales (K Units) by Application (2020-2025)
 Table 61. Global Sterile Lancets Sales (K Units) by Application (2026-2031)
 Table 62. Global Sterile Lancets Sales Market Share by Application (2020-2025)
 Table 63. Global Sterile Lancets Sales Market Share by Application (2026-2031)
 Table 64. Global Sterile Lancets Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Sterile Lancets Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Sterile Lancets Revenue Market Share by Application (2020-2025)
 Table 67. Global Sterile Lancets Revenue Market Share by Application (2026-2031)
 Table 68. Global Sterile Lancets Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Sterile Lancets Price (US$/Unit) by Application (2026-2031)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Roche Sterile Lancets Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Lifescan Company Information
 Table 76. Lifescan Description and Business Overview
 Table 77. Lifescan Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Lifescan Sterile Lancets Product
 Table 79. Lifescan Recent Developments/Updates
 Table 80. BD Company Information
 Table 81. BD Description and Business Overview
 Table 82. BD Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. BD Sterile Lancets Product
 Table 84. BD Recent Developments/Updates
 Table 85. Ascensia Company Information
 Table 86. Ascensia Description and Business Overview
 Table 87. Ascensia Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Ascensia Sterile Lancets Product
 Table 89. Ascensia Recent Developments/Updates
 Table 90. Abbott Company Information
 Table 91. Abbott Description and Business Overview
 Table 92. Abbott Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Abbott Sterile Lancets Product
 Table 94. Abbott Recent Developments/Updates
 Table 95. B. Braun Company Information
 Table 96. B. Braun Description and Business Overview
 Table 97. B. Braun Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. B. Braun Sterile Lancets Product
 Table 99. B. Braun Recent Developments/Updates
 Table 100. ARKRAY Company Information
 Table 101. ARKRAY Description and Business Overview
 Table 102. ARKRAY Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. ARKRAY Sterile Lancets Product
 Table 104. ARKRAY Recent Developments/Updates
 Table 105. Terumo Company Information
 Table 106. Terumo Description and Business Overview
 Table 107. Terumo Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Terumo Sterile Lancets Product
 Table 109. Terumo Recent Developments/Updates
 Table 110. I-SENS Company Information
 Table 111. I-SENS Description and Business Overview
 Table 112. I-SENS Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. I-SENS Sterile Lancets Product
 Table 114. I-SENS Recent Developments/Updates
 Table 115. Nipro Company Information
 Table 116. Nipro Description and Business Overview
 Table 117. Nipro Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Nipro Sterile Lancets Product
 Table 119. Nipro Recent Developments/Updates
 Table 120. Cardinal Health Company Information
 Table 121. Cardinal Health Description and Business Overview
 Table 122. Cardinal Health Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Cardinal Health Sterile Lancets Product
 Table 124. Cardinal Health Recent Developments/Updates
 Table 125. ICU Medical Company Information
 Table 126. ICU Medical Description and Business Overview
 Table 127. ICU Medical Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. ICU Medical Sterile Lancets Product
 Table 129. ICU Medical Recent Developments/Updates
 Table 130. Sarstedt Company Information
 Table 131. Sarstedt Description and Business Overview
 Table 132. Sarstedt Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Sarstedt Sterile Lancets Product
 Table 134. Sarstedt Recent Developments/Updates
 Table 135. Sinocare Company Information
 Table 136. Sinocare Description and Business Overview
 Table 137. Sinocare Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Sinocare Sterile Lancets Product
 Table 139. Sinocare Recent Developments/Updates
 Table 140. Yicheng Company Information
 Table 141. Yicheng Description and Business Overview
 Table 142. Yicheng Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Yicheng Sterile Lancets Product
 Table 144. Yicheng Recent Developments/Updates
 Table 145. Yuwell Company Information
 Table 146. Yuwell Description and Business Overview
 Table 147. Yuwell Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Yuwell Sterile Lancets Product
 Table 149. Yuwell Recent Developments/Updates
 Table 150. Greiner Bio One Company Information
 Table 151. Greiner Bio One Description and Business Overview
 Table 152. Greiner Bio One Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Greiner Bio One Sterile Lancets Product
 Table 154. Greiner Bio One Recent Developments/Updates
 Table 155. Guangzhou iCare Medical Company Information
 Table 156. Guangzhou iCare Medical Description and Business Overview
 Table 157. Guangzhou iCare Medical Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Guangzhou iCare Medical Sterile Lancets Product
 Table 159. Guangzhou iCare Medical Recent Developments/Updates
 Table 160. Shandong Lianfa Company Information
 Table 161. Shandong Lianfa Description and Business Overview
 Table 162. Shandong Lianfa Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Shandong Lianfa Sterile Lancets Product
 Table 164. Shandong Lianfa Recent Developments/Updates
 Table 165. Tianjin Huahong Company Information
 Table 166. Tianjin Huahong Description and Business Overview
 Table 167. Tianjin Huahong Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Tianjin Huahong Sterile Lancets Product
 Table 169. Tianjin Huahong Recent Developments/Updates
 Table 170. Owen Mumford Company Information
 Table 171. Owen Mumford Description and Business Overview
 Table 172. Owen Mumford Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. Owen Mumford Sterile Lancets Product
 Table 174. Owen Mumford Recent Developments/Updates
 Table 175. HemoCue Company Information
 Table 176. HemoCue Description and Business Overview
 Table 177. HemoCue Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 178. HemoCue Sterile Lancets Product
 Table 179. HemoCue Recent Developments/Updates
 Table 180. HTL-STREFA Company Information
 Table 181. HTL-STREFA Description and Business Overview
 Table 182. HTL-STREFA Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 183. HTL-STREFA Sterile Lancets Product
 Table 184. HTL-STREFA Recent Developments/Updates
 Table 185. UltiMed Company Information
 Table 186. UltiMed Description and Business Overview
 Table 187. UltiMed Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 188. UltiMed Sterile Lancets Product
 Table 189. UltiMed Recent Developments/Updates
 Table 190. SteriLance Medical Company Information
 Table 191. SteriLance Medical Description and Business Overview
 Table 192. SteriLance Medical Sterile Lancets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 193. SteriLance Medical Sterile Lancets Product
 Table 194. SteriLance Medical Recent Developments/Updates
 Table 195. Key Raw Materials Lists
 Table 196. Raw Materials Key Suppliers Lists
 Table 197. Sterile Lancets Distributors List
 Table 198. Sterile Lancets Customers List
 Table 199. Sterile Lancets Market Trends
 Table 200. Sterile Lancets Market Drivers
 Table 201. Sterile Lancets Market Challenges
 Table 202. Sterile Lancets Market Restraints
 Table 203. Research Programs/Design for This Report
 Table 204. Key Data Information from Secondary Sources
 Table 205. Key Data Information from Primary Sources
 Table 206. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Sterile Lancets
 Figure 2. Global Sterile Lancets Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Sterile Lancets Market Share by Type: 2024 & 2031
 Figure 4. Safety Lancets Product Picture
 Figure 5. Ordinary Lancets Product Picture
 Figure 6. Global Sterile Lancets Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Sterile Lancets Market Share by Application: 2024 & 2031
 Figure 8. Children's Fingertip Blood Tests
 Figure 9. Glucose Tests
 Figure 10. Others
 Figure 11. Global Sterile Lancets Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Sterile Lancets Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Sterile Lancets Sales (2020-2031) & (K Units)
 Figure 14. Global Sterile Lancets Average Price (US$/Unit) & (2020-2031)
 Figure 15. Sterile Lancets Report Years Considered
 Figure 16. Sterile Lancets Sales Share by Manufacturers in 2024
 Figure 17. Global Sterile Lancets Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Sterile Lancets Players: Market Share by Revenue in Sterile Lancets in 2024
 Figure 19. Sterile Lancets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Sterile Lancets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Sterile Lancets Sales Market Share by Country (2020-2031)
 Figure 22. North America Sterile Lancets Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Sterile Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Sterile Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Sterile Lancets Sales Market Share by Country (2020-2031)
 Figure 26. Europe Sterile Lancets Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Sterile Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Sterile Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Sterile Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Sterile Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Sterile Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Sterile Lancets Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Sterile Lancets Revenue Market Share by Region (2020-2031)
 Figure 34. China Sterile Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Sterile Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Sterile Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Sterile Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Sterile Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Sterile Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Sterile Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Sterile Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Sterile Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Sterile Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Sterile Lancets Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Sterile Lancets Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Sterile Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Sterile Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Sterile Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Sterile Lancets Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Sterile Lancets Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Sterile Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Sterile Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Sterile Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Sterile Lancets by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Sterile Lancets by Type (2020-2031)
 Figure 56. Global Sterile Lancets Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Sterile Lancets by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Sterile Lancets by Application (2020-2031)
 Figure 59. Global Sterile Lancets Price (US$/Unit) by Application (2020-2031)
 Figure 60. Sterile Lancets Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart